The First FDA-Approved Digital Pill — What It Means For Pharma Harsha Madannavar Justin Wang Helen Chen Read more
Related Practice Life Sciences & Pharma In mid-November 2017, the U.S. FDA approved Japan-based Otsuka Pharmaceutical’s Abilify MyCite— a first for digital medicine. 07312019140709
Published Articles Sustainability To Meet Decarbonization Targets, Master The Circular Economy July 9, 2024
Executive Insights Life Sciences & Pharma First vs. Best in Class — Simplifying the Equation for Biopharma June 27, 2024
Podcast Life Sciences & Pharma Scope 3 Emissions: A Strategic Imperative for Pharma Companies May 8, 2024
Article Life Sciences & Pharma The New Map – Shifting geographic priorities for healthcare companies operating in Asia November 1, 2023